Navigation Links
Settlement Hearing for In Re PainCare Holdings, Inc. ("PRZ") Securities Litigation
Date:6/30/2008

Class Action To Be Held on September 15, 2008 at 9:30 a.m.

PHILADELPHIA, June 30 /PRNewswire/ -- Plaintiffs' counsel in the PainCare Holdings, Inc. Securities Litigation class action today announced the following:

United States District Court

Middle District of Florida -- Orlando Division

In re PainCare Holdings, Inc. Securities Litigation

6:06-cv-362-Orl-28DAB

Summary Notice of Pendency of Class Action,

Proposed Settlement, Motion for Final Approval

of Settlement and Attorneys' Fees

If you purchased or otherwise acquired PainCare Holdings, Inc. ("PainCare") common stock during the period between March 24, 2003 and March 15, 2006, inclusive (the "Class Period") and were damaged thereby, and are not otherwise excluded from the settlement class, then you could receive a payment from the proposed settlement of a securities class action.

A settlement has been proposed in a class action about the alleged inflation of the price of PainCare common stock during the Class Period. The settlement will provide a settlement fund of two million dollars ($2,000,000) for the benefit of investors who purchased PainCare common stock during the Class Period. If you qualify, you may send in a claim form to get benefits, you can exclude yourself from the settlement, or you can object to the settlement.

The United States District Court for the Middle District of Florida, Orlando Division, authorized this Summary Notice. Before any money is paid, the Court will hold a hearing to decide whether to approve the settlement.

Who is included?

You are a Class Member if you purchased PainCare publicly-traded common stock during the period between March 24, 2003 and March 15, 2006, inclusive, and were damaged thereby. If you still are unsure whether you are included you can ask for help. You can call 1-800-252-5745, toll free, or visit

SOURCE Barrack, Rodos & Bacine
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
2. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
3. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
4. $52.5 Million Settlement Against Sepracor Inc. Approved
5. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
6. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
7. UGA study: Youth exposed to smokeless tobacco ads despite settlement
8. AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout
9. AK Steel Reaches VEBA Health Care Settlement With Middletown Works Retirees
10. Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power
11. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck...asbestos have been found in toys in past holiday s...RWEB) December 6, 2009 -- As parents shop for chil... be alert to reports of recalls due to lead paint ...l injury lawyer., , ,“Close to 230,000 child...
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
Breaking Medicine News(10 mins):Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
...ON, May 18 Dr. Andree Bates, President of the Pha...ivering a MasterClass on how to tell if you are ma... Eularis, WHAT: MasterClass on the latest t... WHEN: 12 June 2009, WHERE: 1 Northumberlan...
...ston) - African-American women who were younger at..., were more likely to report a history of childhoo...researcher at Boston University,s Slone Epidemiolo...years). , The study, which appears currently on-l...
...d volume perfusion acquisition, intuitive post-pro...ngine for comprehensive workflow efficiency and pa...d leading cause of death in the United States, str...irst few hours are the defining time when a quick ...
...NING, Germany and FREMONT, Calif., May 18 SCM Mic...SMY), a leading provider of solutions that open th...500 mobile terminal is one of the first upgradeab...d in Germany. , , "With the certification of our...
...RCLIFF MANOR, N.Y., May 18 SETO Holdings, Inc. (P...itive agreement to acquire from Sanjay Srivastava ...ers, Inc. ("AHC"), a Maryland corporation formed i...f the AHC acquisition that the public company shal...
...al trials using new strategies show promise for be...y 18 (HealthDay News) -- Vaccines made up of virus...longer-lasting protection against flu viruses than...ce as quickly as conventional vaccines, according ...
Other Medicine News:Health News:MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London 2Health News:Study finds higher prevalence of early menarche among survivors of childhood sexual abuse 2Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 2Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 3Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 4Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 2Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 3Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 4Health News:SETO Holdings, Inc. Signs Agreement to Acquire Advanced Hearing Centers, Inc. and Will Dispose of All Existing Business; New Management to be Installed 2Health News:New Methods Could Speed Production of Flu Vaccines 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 1AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 2AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 3Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 8857 1Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 8857 2Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 1Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 2
... Animal Use in Cosmetics and Chemicals Testing, A...d,that results of a recently completed US and Euro...on MatTek,s EpiDerm in vitro human skin tissue,equ...d sensitivity and,specificity for EpiDerm to be ac...g for determining human skin irritation by the Eur...
...am to evaluate TAXUS(R) Element(TM) Platinum Chrom..., Mass., Oct. 8 Boston Scientific,Corporation (NY...nrollment in,the PERSEUS trial, designed to evalua...(TM) paclitaxel-eluting coronary stent. The PERSEU...nts at 100 U.S. and,international centers since Ju...
Other Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4
Impulse II
Slimtine S
Fineline II Sterox Atrial J
VascoTip P 9/60 PU M
Medicine Products: